---
title: "[Stock Movement] EXTRAWELL PHAR once surged over 50%, expected to turn from loss to profit in mid-term results"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/220158474.md"
description: "The profit warning from EXTRAWELL PHAR caused its stock price to surge this morning, rising by as much as 54.2% to a high of HKD 0.074, while the new offer was HKD 0.066, still up 37.5%, making it the stock with the largest increase. The transaction volume was HKD 1.4 million. The group issued a profit warning, expecting to turn a profit for the interim results ending September this year, with earnings reaching HKD 100 million to HKD 105 million, due to gains from the fair value changes of non-cash items. Try EJFQ \"Signal\" comprehensive stock analysis system now, using 100+ stock selection criteria to filter valuable stocks!"
datetime: "2024-11-20T03:07:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/220158474.md)
  - [en](https://longbridge.com/en/news/220158474.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/220158474.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/220158474.md) | [繁體中文](https://longbridge.com/zh-HK/news/220158474.md)


# [Stock Movement] EXTRAWELL PHAR once surged over 50%, expected to turn from loss to profit in mid-term results

發盈喜的精優藥業 (00858)，股價今早炒上，一度大升 54.2%，高見 0.074 元，新造 0.066 元，仍急升 37.5%，為升幅最大個股，成交有 140 萬元。

集團發盈喜，料截至今年 9 月底止中期業績扭虧為盈，盈利達 1 億至 1.05 億元，因非現金項目公平值變動產生收益所致。

立即試用EJFQ「信號」全方位股票分析系統，運用 100+ 選股條件篩選值博股！

### 相关股票

- [EXTRAWELL PHAR (00858.HK)](https://longbridge.com/zh-CN/quote/00858.HK.md)

## 相关资讯与研究

- [Uber increases stake in WeRide as robotaxi partnership ramps up in Dubai](https://longbridge.com/zh-CN/news/281219301.md)
- [Butong Group Expands Share Pool for Award Scheme With On-Market Purchase](https://longbridge.com/zh-CN/news/280828310.md)
- [ZAWYA-PRESSR: ITIDA and plug and play conclude Aswan bootcamp series as startups secure EGP 200mln in Upper Egypt](https://longbridge.com/zh-CN/news/281122065.md)
- [BUZZ-Gold miners gain as bullion prices tick higher](https://longbridge.com/zh-CN/news/281178839.md)
- [SSY Group Wins China Approval for Upadacitinib Bulk Drug](https://longbridge.com/zh-CN/news/281103720.md)